Silica-Coated Ga(III)-Doped ZnO: Yb3+, Tm3+ Upconversion Nanoparticles for High-Resolution in Vivo Bioimaging using Near-Infrared to Near-Infrared Upconversion Emission

Nanomaterials for light-mediated therapeutics in deep tissue

Light-mediated therapeutics, including photodynamic therapy, photothermal therapy and light-triggered drug delivery, have been widely studied due to their high specificity and effective therapy. However, conventional light-mediated therapies usually depend on the activation of light-sensitive molecules with UV or visible light, which have poor penetration in biological tissues. Over the past decade, efforts have been made to engineer nanosystems that can generate luminescence through excitation with near-infrared (NIR) light, ultrasound or X-ray. Certain nanosystems can even carry out light-mediated therapy through chemiluminescence, eliminating the need for external activation. Compared to UV or visible light, these 4 excitation modes penetrate more deeply into biological tissues, triggering light-mediated therapy in deeper tissues. In this review, we systematically report the design and mechanisms of different luminescent nanosystems excited by the 4 excitation sources, methods to enhance the generated luminescence, and recent applications of such nanosystems in deep tissue light-mediated therapeutics.

Activating ultralow upconversion nanothermometry in neodymium sublattice for heart tissue imaging rapid-responsive

The fields of biosensitivity and biological imaging have received a lot of attention from rare earth-doped upconversion nanoparticles (UCNPs). However, owing to the relatively large energy difference of rare earth ions, biological sensitivity based on UCNPs is restricted to detect at low temperature. Here, we design core-shell-shell NaErF₄:Yb@Nd₂O₃@SiO₂ UCNPs as a dual-mode bioprobe that produces blue, green, and red multi-color upconversion emissions at extremely low temperatures between 100 K and 280 K. Based on the thermally coupled energy levels (TCELs) of Er³⁺ (²H_11/2 and ⁴S_3/2) and Nd³⁺ (⁴F_5/2 and ⁴F_3/2) at 100 K, the greatest relative sensitivity (S_R) approaches 12.7% K^-1. NaErF₄:Yb@Nd₂O₃@SiO₂ injection is used to achieve blue upconversion emission imaging of frozen heart tissue, showing that this UCNP can serve as a low-temperature sensitive biological fluorescence.

Recent Advances in ZnO Nanomaterial-Mediated Biological Applications and Action Mechanisms

In recent years, with the deepening research, metal zinc oxide (ZnO) nanomaterials have become a popular research object in the biological field, particularly in biomedicine and food safety, which is attributed to their unique physicochemical properties such as high surface area and volume ratio, luminescence effect, surface characteristics and biological activities. Herein, this review provides a detailed overview of the ZnO nanomaterial-mediated biological applications that involve anti-bacterial, anti-tumor, anti-inflammation, skin care, biological imaging and food packaging applications. Importantly, the corresponding action mechanisms of ZnO nanomaterials are pointed. Additionally, the structure and structure-dependent physicochemical properties, the common synthesis methods and the biosafety of ZnO nanoparticles are revealed in brief. Finally, the significance and future challenges of ZnO nanomaterial applications are concluded.

Dual-Mode nanoprobes for heart tissue imaging

A new method that simultaneously alters multicolor upconversion luminescence (UCL) and improves overall UCL intensity, predominantly in red-emission bands, is presented here. Remarkedly enhanced temperature sensitivity at ultralow temperatures was also observed in Yb/Cu co-doped NaErF₄ through transition metal Cu²⁺-doping. Varying the dopant (Cu²⁺) concentration in NaErF₄:Yb effectively controlled the structure, allowing for blue, green, and red UCL output. Large enhancement across the entire UCL spectrum was observed for Cu²⁺-doped upconversion nanoparticles (UCNPs) compared to UCNPs not doped with Cu²⁺, resulting from non-radiative energy transfer between Cu²⁺ and Er³⁺. The rapid response of the NaErF₄:Yb/Cu complex allowed for bioimaging of heart tissue within 1 h. Moreover, the relative sensitivity of UCNPs increased from 0.91% K^-1 to 1.48% K^-1 with metal Cu²⁺ doping at an ultralow temperature, which significantly impacts biomarker dependence on UCNPs.

Recent advances in ZnO-based photosensitizers: Synthesis, modification, and applications in photodynamic cancer therapy

Zinc oxide nanoparticles (ZnO NPs) are important semiconductor materials with interesting photo-responsive properties. During the past, ZnO-based NPs have received considerable attention for photodynamic therapy (PDT) due to their biocompatibility and excellent potential of generating tumor-killing reactive oxygen species (ROS) through gentle photodynamic activation. This article provides a comprehensive review of the recent developments and improvements in optical properties of ZnO NPs as photosensitizers for PDT. The optical properties of ZnO-based photosensitizers are significantly dependent on their charge separation, absorption potential, band gap engineering, and surface area, which can be adjusted/tuned by doping, compositing, and morphology control. Here, we first summarize the recent progress in the charge separation capability, absorption potential, band gap engineering, and surface area of nanosized ZnO-based photosensitizers. Then, morphology control that is closely related to their synthesis method is discussed. Following on, the state-of-art for the ZnO-based NPs in the treatment of hypoxic tumors is comprehensively reviewed. Finally, we provide some outlooks on common targeted therapy methods for more effective tumor killing, including the attachment of small molecules, antibodies, ligands molecules, and receptors to NPs which further improve their selective distribution and targeting, hence improving the therapeutic effectiveness. The current review may provide useful guidance for the researchers who are interested in this promising dynamic cancer treatment technology.

Upconversion Nanoparticle Powered Microneedle Patches for Transdermal Delivery of siRNA

Microneedles (MNs) permit the delivery of nucleic acids like small interfering RNA (siRNA) through the stratum corneum and subsequently into the skin tissue. However, skin penetration is only the first step in successful implementation of siRNA therapy. These delivered siRNAs need to be resistant to enzymatic degradation, enter target cells, and escape the endosome-lysosome degradation axis. To address this challenge, this article introduces a nanoparticle-embedding MN system that contains a dissolvable hyaluronic acid (HA) matrix and mesoporous silica-coated upconversion nanoparticles (UCNPs@mSiO₂ ). The mesoporous silica (mSiO₂ ) shell is used to load and protect siRNA while the upconversion nanoparticle (UCNP) core allows the tracking of MN skin penetration and NP diffusion through upconversion luminescence imaging or optical coherence tomography (OCT) imaging. Once inserted into the skin, the HA matrix dissolves and UCNPs@mSiO₂ diffuse in the skin tissue before entering the cells for delivering the loaded genes. As a proof of concept, this system is used to deliver molecular beacons (MBs) and siRNA targeting transforming growth factor-beta type I receptor (TGF-βRI) that is potentially used for abnormal scar treatment.